• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[LY294002增强K562细胞对柔红霉素的化疗敏感性]

[LY294002 Enhaces Chemosensitivity of K562 Cells to Daunorubicin].

作者信息

Geng Ying-Hua, Wu Wen-Juan, Li Jun, Zhou Li-Li, Yang Yan-Li

机构信息

Department of Hematology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, Anhui Province, China,E-mail:

Department of Biochemistry and Molecular Biology, Bengbu Medical College, Bengbu 233030, Anhui Province, China.

出版信息

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Feb;28(1):110-118. doi: 10.19746/j.cnki.issn.1009-2137.2020.01.019.

DOI:10.19746/j.cnki.issn.1009-2137.2020.01.019
PMID:32027262
Abstract

OBJECTIVE

To investigate the proliferation inhibition and pro-apoptosis effect of LY294002 (PI3K/AKT inhibtor) combined with daunorubicin (DNR) on the chronic myeloid leurenia cell line K562 and its possible mechanisms.

METHODS

The effect of LY294002 and DNR on the proliferation of K562 cells in different treating time and concentration were measured by MTT assay. The cell cycle was determined by flow cytometry, the mRNA and protein expression of SKP2 , P27, BCL-2 and BAX were determined by RT-PCR and Western blot.

RESULTS

LY294002 and DNR were able to inhibit the growth of K562 cells and promote apoptosis in time- and concentration-dependent manner (P<0.05), both the cell proliferation-inhibiting rate and apoptosis rate in combination therapy group were higher than that in DNR-monotherapy group (P<0.05). After K562 cells treated by LY294002 combined DNR for 36 h, the cells were statistically significantly reduced in G/M phase (P<0.05), as compared with control group and DNR group. Compared with DNR group, the cell level of G/G phase rased (P<0.05) and cell level of S phase decreased (P>0.05). Compared with DNR group, the expresson of SKP2 and BCL-2 mRNA decreased, and the expression of P27 mRNA increased in the combination therapy group (P<0.05). The expression of BAX mRNA was not significantly different between different groups. The same result was found in the protein expression.

CONCLUSION

LY294002 has the sensibilizative effect on DNR chemotherapy, which may be relative with blocking the cell cycle and inducing cell apoptosis.

摘要

目的

探讨LY294002(PI3K/AKT抑制剂)联合柔红霉素(DNR)对慢性髓性白血病细胞系K562的增殖抑制及促凋亡作用及其可能机制。

方法

采用MTT法检测LY294002和DNR在不同作用时间和浓度下对K562细胞增殖的影响。通过流式细胞术检测细胞周期,采用RT-PCR和Western blot检测SKP2、P27、BCL-2和BAX的mRNA及蛋白表达。

结果

LY294002和DNR均能抑制K562细胞生长并促进其凋亡,呈时间和浓度依赖性(P<0.05),联合治疗组的细胞增殖抑制率和凋亡率均高于DNR单药治疗组(P<0.05)。LY294002联合DNR作用K562细胞36 h后,与对照组和DNR组相比,G/M期细胞比例统计学显著降低(P<0.05)。与DNR组相比,联合治疗组G/G期细胞比例升高(P<0.05),S期细胞比例降低(P>0.05)。联合治疗组与DNR组相比,SKP2和BCL-2 mRNA表达降低,P27 mRNA表达升高(P<0.05)。不同组间BAX mRNA表达无显著差异。蛋白表达结果相同。

结论

LY294002对DNR化疗具有增敏作用,可能与阻滞细胞周期及诱导细胞凋亡有关。

相似文献

1
[LY294002 Enhaces Chemosensitivity of K562 Cells to Daunorubicin].[LY294002增强K562细胞对柔红霉素的化疗敏感性]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Feb;28(1):110-118. doi: 10.19746/j.cnki.issn.1009-2137.2020.01.019.
2
Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.PI3-K抑制剂LY294002对人白血病细胞系K562/DNR及胃癌细胞系SGC7901/ADR中P-糖蛋白介导的多药耐药的逆转作用
Ai Zheng. 2009 Feb;28(2):97-9. Epub 2009 Feb 23.
3
[Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA].[紫铆因独立于P-糖蛋白和多药耐药基因1信使核糖核酸逆转K562/D对柔红霉素的多药耐药性]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Oct;25(5):1342-1349. doi: 10.7534/j.issn.1009-2137.2017.05.011.
4
[Navitoclax Combined with Daunorubicin Promotes Apoptosis of Erythroleukemia Cell Lines K562, HEL and TF-1].维奈托克联合柔红霉素促进红白血病细胞系K562、HEL和TF-1凋亡
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Jun;28(3):724-730. doi: 10.19746/j.cnki.issn.1009-2137.2020.03.002.
5
[Effect of Expression Interference on Daunorubicin Chemosensitivity of Chronic Myeloid Leukemia K562 Cells and Its Mechanism].[表达干扰对慢性髓系白血病K562细胞柔红霉素化疗敏感性的影响及其机制]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Feb;32(1):45-51. doi: 10.19746/j.cnki.issn.1009-2137.2024.01.008.
6
[Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].[PI3K和MEK的联合抑制对顺铂耐药卵巢癌细胞的增殖具有协同抑制作用]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jun;30(6):592-6.
7
Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.抑制 PI3K/Akt 通路可提高胃癌对长春新碱的化疗敏感性。
Oncol Rep. 2013 Aug;30(2):773-82. doi: 10.3892/or.2013.2520. Epub 2013 Jun 5.
8
[Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].葡糖神经酰胺合酶抑制剂PDMP对人白血病细胞系K562/A02柔红霉素耐药逆转的作用
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Feb;18(1):79-84.
9
[Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells].5-溴粉防己碱与柔红霉素对K562/A02细胞凋亡及生存素表达的影响
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Feb;19(1):24-7.
10
[Effects of matrine combined with LY294002 on proliferation, apoptosis and cell cycle of human myeloid leukemia K562 cells].苦参碱联合LY294002对人髓系白血病K562细胞增殖、凋亡及细胞周期的影响
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Nov 20;42(11):1739-1746. doi: 10.12122/j.issn.1673-4254.2022.11.20.

引用本文的文献

1
[Effects of matrine combined with LY294002 on proliferation, apoptosis and cell cycle of human myeloid leukemia K562 cells].苦参碱联合LY294002对人髓系白血病K562细胞增殖、凋亡及细胞周期的影响
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Nov 20;42(11):1739-1746. doi: 10.12122/j.issn.1673-4254.2022.11.20.